Published in Allergy on July 01, 1980
HLA antigens and atopy in children with coeliac disease. Gut (1983) 0.99
Is the prevalence of atopy increasing? Br J Gen Pract (1990) 0.94
Atopic sensitization to common allergens without symptoms or signs of airway disorders does not increase exhaled nitric oxide. Clin Respir J (2008) 0.88
Prevalence of sensitization to food allergens and challenge proven food allergy in patients visiting allergy centers in Rawalpindi and Islamabad, Pakistan. Springerplus (2016) 0.75
Prevalence of childhood allergic diseases in Adana, Southern Turkey. Eur J Epidemiol (1998) 0.75
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07
Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis (1985) 4.59
Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ (1996) 3.79
No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy (2002) 2.99
The Brussels Declaration: the need for change in asthma management. Eur Respir J (2008) 2.91
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study). Arch Dis Child (2007) 2.33
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol (1992) 2.16
Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet (1993) 1.98
Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax (2003) 1.94
Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy (2002) 1.82
Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy (2005) 1.75
Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis (1993) 1.73
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72
Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response? Am J Respir Cell Mol Biol (2000) 1.61
Incidence of occupational asthma and persistent asthma in young adults has increased in Finland. Chest (1996) 1.61
Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin Exp Allergy (2002) 1.59
The roles of iron in health and disease. Mol Aspects Med (2001) 1.55
Nutritional modulation of exercise-induced immunodepression in athletes: a systematic review and meta-analysis. Eur J Clin Nutr (2006) 1.51
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
The GINA Asthma Challenge: reducing asthma hospitalisations. Eur Respir J (2011) 1.45
Asthma and atopy - the price of affluence? Allergy (2004) 1.45
Is atopy a risk factor for the use of contact lenses? Allergy (1992) 1.44
Can early asthma be confirmed by laboratory tests? Allergy (1996) 1.42
Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. BMJ (1998) 1.38
A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet (2001) 1.36
The South Karelia Air Pollution Study. The effects of malodorous sulfur compounds from pulp mills on respiratory and other symptoms. Am Rev Respir Dis (1990) 1.34
Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy (2005) 1.25
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy (2011) 1.22
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22
Reduction of asthma burden is possible through National Asthma Plans. Allergy (2010) 1.21
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol (2000) 1.18
Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol (1998) 1.17
Allergy and asthma in elite summer sport athletes. J Allergy Clin Immunol (2000) 1.17
Mycotoxins in crude building materials from water-damaged buildings. Appl Environ Microbiol (2000) 1.13
Neonatal birch-pollen contact and subsequent allergy to birch pollen. Clin Allergy (1980) 1.11
Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy (2008) 1.10
Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J (2000) 1.04
Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging (2002) 1.04
Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol (2006) 1.03
GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy (2009) 1.03
Signs of reversing trends in prevalence of asthma. Allergy (2005) 1.03
Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland. Clin Exp Allergy (2006) 1.03
Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med (1998) 1.02
Do infections in infancy affect sensitization to airborne allergens and development of atopic disease? A retrospective study of seven-year-old children. Allergy (1984) 1.02
Exposure to hydrogen sulphide and respiratory function. Br J Ind Med (1990) 1.01
Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (part I). Allergy (2013) 0.99
Allergy gap between Finnish and Russian Karelia on increase. Allergy (2011) 0.99
Hypersensitivity reactions to food additives. Allergy (1987) 0.98
Association between type of training and risk of asthma in elite athletes. Thorax (1997) 0.98
Farmer's lung--a 5-year follow-up of eighty-six patients. Clin Allergy (1987) 0.97
Adherence to the Mediterranean diet and fresh fruit intake are associated with improved asthma control. Allergy (2008) 0.96
Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease. COPD (2009) 0.96
Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis (1991) 0.96
Expression of a novel human ornithine decarboxylase-like protein in the central nervous system and testes. Biochem Biophys Res Commun (2001) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Radiologic findings in farmer's lung. Prognosis and correlation to lung function. Chest (1985) 0.95
Time and intensity of first pollen contacts and risk of subsequent pollen allergies. Acta Med Scand (1981) 0.95
True adherence with the Turbuhaler in young children with asthma. Arch Dis Child (2010) 0.95
Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers. Allergy (1998) 0.95
Occurrence of dog, cat, and mite allergens in public transport vehicles. Allergy (2000) 0.94
Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions. J Allergy Clin Immunol (1999) 0.94
Reference values for respiratory system impedance by using impulse oscillometry in children aged 2-11 years. Clin Physiol Funct Imaging (2006) 0.94
Exercise-induced bronchospasm at low temperature in elite runners. Thorax (1996) 0.93
Toxic-metabolite-producing bacteria and fungus in an indoor environment. Appl Environ Microbiol (2001) 0.93
Deletion mapping of the human X chromosome. Hereditas (1975) 0.92
Asthma and allergic rhinitis among Finnish adolescents in 1977-1991. Scand J Soc Med (1995) 0.91
Bronchial hyperreactivity to inhaled histamine in patients with farmer's lung. Lung (1981) 0.90
Non-specific bronchial reactivity and ultrastructure of the airway epithelium in patients with sarcoidosis and allergic alveolitis. Eur J Respir Dis Suppl (1983) 0.89
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function. Eur Respir J (2008) 0.89
Balanced physiological saline in the treatment of chronic rhinitis. Rhinology (1986) 0.89
The South Karelia Air Pollution Study: changes in respiratory health in relation to emission reduction of malodorous sulfur compounds from pulp mills. Arch Environ Health (1999) 0.88
Dependence of immediate hypersensitivity on the month of birth. Clin Allergy (1976) 0.88
Davos declaration: allergy as a global problem. Allergy (2012) 0.88
Opposite gene by environment interactions in Karelia for CD14 and CC16 single nucleotide polymorphisms and allergy. Allergy (2009) 0.88
Physical training does not increase allergic inflammation in asthmatic children. Eur Respir J (2008) 0.88
Changes in frequency spectra of breath sounds during histamine challenge test in adult asthmatics and healthy control subjects. Chest (1994) 0.88
Microbial content of drinking water in Finnish and Russian Karelia - implications for atopy prevalence. Allergy (2007) 0.87
Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus. Chest (1986) 0.87
Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. Ann Allergy Asthma Immunol (2001) 0.86
Change in the pattern of IgE reactivity to timothy grass and birch pollen allergens over a 20-year period. J Investig Allergol Clin Immunol (2006) 0.86
Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy (1999) 0.86
Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum-processing methods. Respir Med (2001) 0.86
The South Karelia Air Pollution Study: effects of low-level exposure to malodorous sulfur compounds on symptoms. Arch Environ Health (1996) 0.86
Persistent asthma, comorbid conditions and the risk of work disability: a prospective cohort study. Allergy (2011) 0.86
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy (2006) 0.84
Detection and treatment of early asthma. Allergy (2000) 0.84
Allergic rhinitis and asthma have generally good outcome and little effect on quality of life - a 20-year follow-up. Allergy (2011) 0.84
Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration. J Allergy Clin Immunol (2001) 0.84
Effects of inhaled corticosteroids on metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in the airways of asthmatic children. Int Arch Allergy Immunol (2009) 0.84
Respiratory symptoms, bronchial hyper-responsiveness, and eosinophilic airway inflammation in patients with moderate-to-severe atopic dermatitis. Clin Exp Allergy (2006) 0.84
Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults. Eur Respir J (2010) 0.83